Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07143019 · ClinicalTrials.gov registry record · NA
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
A NA study of Hemorrhagic Stroke and Aneurysm, Intracranial, sponsored by phenox.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 8
- Study locations
NCT07143019 is a NA study of Hemorrhagic Stroke and Aneurysm, Intracranial that is actively recruiting participants, run by phenox. The registered enrollment target is 214 participants, below the 10,362-participant average among 6 other Hemorrhagic Stroke trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT07143019, a NA study of Hemorrhagic Stroke and Aneurysm, Intracranial, is actively recruiting participants, sponsored by phenox.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 8
- Study locations
Study Summary
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC flow diverter in the treatment of wide-necked intracranial aneurysms.
Conditions Studied
Interventions
- DEVICE Flow diversion
Study Locations (8)
Colorado
- University of Colorado Anschutz - Aurora
- Swedish Medical Research Center - Englewood
New York
- UBNS - Buffalo
- North Shore University Hospital - Northwell Health - Manhasset
Arizona
- Barrow Neurological Institute - Phoenix
Florida
- Baptist Health Research Institute - Jacksonville
Massachusetts
- Tufts Medical Center - Boston
Washington
- University of Washington - Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2026-02 |
| Est. Completion | 2032-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07143019
The ClinicalTrials.gov registry entry for NCT07143019 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,362-participant average among 6 other Hemorrhagic Stroke trials with a reported enrollment target (98% lower). The listed sponsor is phenox, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Hemorrhagic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Flow diversion is the first listed.
NCT07143019 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Colorado, New York, Arizona.
Frequently Asked Questions
What is clinical trial NCT07143019 about?
NCT07143019 is a clinical study titled "The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms". To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC flow diverter in the treatment of wide-necked intracranial aneurysms.
What is the current status of trial NCT07143019?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2026-02. Estimated completion is 2032-06.
What conditions does trial NCT07143019 study?
This clinical trial studies the following conditions: Hemorrhagic Stroke, Aneurysm, Intracranial, Brain Aneurysm, Saccular Aneurysm, Fusiform Aneurysm.
What interventions are being tested in trial NCT07143019?
The interventions under investigation include: Flow diversion (DEVICE).
Who is sponsoring clinical trial NCT07143019?
This trial is sponsored by phenox, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07143019 being conducted?
This trial has 8 study locations across Arizona, Colorado, Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhagic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke
RECRUITING · NA
-
Left Atrial Strain and Cryptogenic Stroke
RECRUITING
-
Stroke Recovery Initiative - Registry for Stroke Research Studies
RECRUITING
-
Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
RECRUITING
-
Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.